生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Pyrrolidinedithiocarbamate ammonium, ranging from 3 to 1000 μM, when used as a pretreatment, dose-dependently reduces IL-8 production in cells[1]. Pyrrolidinedithiocarbamate ammonium functions by inhibiting the activation of NF-κB, effectively diminishing both NF-κB DNA binding and its dependent transcriptional activity. Consequently, the inhibition of NF-κB with pyrrolidinedithiocarbamate ammonium results in decreased IL-8 production by intestinal epithelial cells, underscoring its mechanism of action[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
6.09mL 1.22mL 0.61mL |
30.43mL 6.09mL 3.04mL |
60.87mL 12.17mL 6.09mL |
参考文献 |
---|